The role of aspiration therapy and intragastric botulinum toxin A injection in obesity treatment


Ülger T. G., Tayfur M., ÇAKIROĞLU F. P.

Obesity Medicine, cilt.26, 2021 (Scopus) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 26
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.obmed.2021.100367
  • Dergi Adı: Obesity Medicine
  • Derginin Tarandığı İndeksler: Scopus
  • Anahtar Kelimeler: Aspiration therapy, Botulinum toxin A, Gastric botox, Obesity
  • Ankara Üniversitesi Adresli: Evet

Özet

© 2021 Elsevier LtdAspiration therapy (AT) and intragastric injection of botulinum toxin A (gastric botox) are among the current endoscopic techniques used in the treatment of obesity. Both techniques have been preferred by patients and physicians due to their easy applicability, low risk of complications and reversibility. In this systematic review, it was aimed to assess the role of these techniques in obesity treatment. A comprehensive search of several databases including Cochrane Library, Web of Science and PubMed were conducted. Twenty-six clinical studies (10 studies on AT and 16 studies on gastric botox) were included. According to the obtained results, the effects of gastric botox on gastric emptying rate, appetite and weight loss have not been clarified yet. On the other hand, it is clear that AT is effective in weight loss. However, the complications that AT can cause (cardiac arrhythmia, hypokalemia, hypochloremic hypokalemic metabolic alkalosis) are more serious compared to gastric botox. AT can also cause some eating behavior disorders. Considering the physiological risks associated with AT, it may be important to support patients undergoing AT treatment with some supplements such as potassium chloride. Patients treated with AT should be periodically screened for eating disorders, in addition to medical monitoring.